DSCR9 and pancreatic neoplasm: Under gemcitabine treatment, DSCR9 overexpression increased, whereas miR-21-5p overexpression decreased cell apoptosis; miR-21-5p overexpression significantly reversed the effects of DSCR9 overexpression on pancreatic cancer cell apoptosis (Figure 6E).